- Also called:
- mitochondrial disorder
mitochondrial disease
-
What are mitochondria?
Mitochondria are oval-shaped organelles, or structures within cells, found in most eukaryotic cells. Often referred to as the "powerhouses" of the cell, their primary function is to transform molecules, such as glucose, into ATP (adenosine triphosphate), an energy molecule that fuels cellular processes.
Mitochondrial disease refers to a group of hereditary conditions resulting from mitochondrial dysfunction, which can emerge at any age and vary significantly in severity and clinical presentation. These diseases, affecting at least 1 in 5,000 people worldwide, are diverse in their impact, ranging from mild, single-organ issues to severe, multi-organ illnesses.
4 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are mitochondrial diseases?
Mitochondrial diseases are a diverse group of inherited conditions resulting from dysfunctional mitochondria, impacting cellular energy production. These diseases, affecting at least 1 in 5,000 people, can manifest at any age with a wide range of symptoms, from mild to severe, impacting single or multiple organs.
Most mitochondrial diseases stem from mutations in the nuclear genome, which affect proteins essential for the electron transport chain (ETC). Defects in the ETC impair the production of adenosine triphosphate (ATP), leading to a buildup of unused metabolic byproducts and harmful reactive oxygen species, causing oxidative stress and cell death. Diagnosis involves assessing clinical features, genetic testing, and family history.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How do mitochondrial diseases affect the body's cells?
Mitochondrial diseases disrupt the function of mitochondria, cellular organelles responsible for energy production. These diseases, often hereditary, can emerge at any age and vary significantly in severity.
Mitochondrial dysfunction impairs the electron transport chain (ETC), which is critical for producing adenosine triphosphate (ATP), the main energy source for cells. This deficiency leads to reduced energy production, accumulation of unused metabolic intermediates, and increased production of toxic reactive oxygen species (ROS).
The buildup of unused intermediates can generate damaging by-products like lactic acid, while ROS cause oxidative stress and cell death. The signs and symptoms of mitochondrial disorders are wide-ranging, affecting various organs and systems, particularly those with high energy demands like the nervous and muscular systems.
4 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What symptoms do people with mitochondrial diseases often have?
Mitochondrial diseases, stemming from mitochondrial dysfunction, present a wide array of symptoms that vary based on the organs involved. These symptoms can emerge at any age and range from mild to severe, significantly challenging diagnosis.
Common signs include developmental delay, reduced growth, fatigue, migraine, muscle weakness and pain, cardiomyopathy, liver failure, blindness, optic atrophy, hearing loss, diabetes, and seizures. Clusters of these symptoms may indicate specific syndromes like Leigh syndrome or Kearns-Sayre syndrome.
Diagnosis involves clinical evaluation and genetic testing, with maternal family history offering crucial insights, as these diseases are maternally inherited. Treatment is largely supportive, addressing specific deficits with aids like optical or hearing devices, cardiac pacemakers, or therapies such as coenzyme Q10 or creatine.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How are mitochondrial diseases diagnosed by doctors?
Mitochondrial diseases, stemming from mitochondrial dysfunction, present significant diagnostic challenges due to their diverse clinical and molecular features. Diagnosis is based on clinical observations and genetic testing results. A maternal family history can offer vital clues, as these diseases pass from mother to offspring through maternal lines.
Often, diagnosis requires demonstrating respiratory chain dysfunction by measuring complex activities in muscle tissue from a biopsy. Microscopic examination may reveal muscle ragged red fibers, suggestive of mitochondrial disease. Molecular diagnostic techniques can sometimes identify mtDNA mutations.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
Why are treatments for mitochondrial diseases difficult to develop?
Treatments for mitochondrial diseases are difficult to develop because of the wide spectrum of symptoms, which poses significant challenges to diagnosis. Mitochondrial disorders can be inherited in Mendelian or maternal fashion because mutations may occur in either the nuclear or mitochondrial genome. Also, not all mutations are known, and complete mtDNA analysis is impractical. There is no proven therapy for respiratory chain disorders, though various dietary supplements and cofactors have been tried, and experiments have begun in the area of gene therapy.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
mitochondrial disease, any of several hundred hereditary conditions that result from a functional failure of the mitochondrion, a type of cellular organelle. Mitochondrial diseases can emerge at any age and are enormously diverse in their clinical and molecular features. They range in severity from relatively mild disease that affects just a single organ to debilitating and sometimes fatal illness that affects multiple organs. The wide spectrum of symptoms poses significant challenges to the diagnosis of conditions associated with mitochondrial dysfunction. At least 1 in every 5,000 persons worldwide is affected by mitochondrial disease.
Although some mitochondrial diseases are caused by mutations in the mitochondrial genome (mtDNA), the majority of the conditions are the result of mutations in genes in the nuclear genome, which encodes a number of proteins that are exported and transported to mitochondria in the cell. The proteins are assembled in mitochondria to form the electron transport chain (ETC), the primary energy-generating apparatus of cells. The transfer of electrons from one protein component to the next ultimately enables cells to produce energy in the form of adenosine triphosphate (ATP), which is the main form of energy used by cells and organs in the body. Deficiency in any of the proteins that make up the ETC can impair ATP production and lead to the buildup of unused intermediates (the initial sugar and fat molecules that enter the ETC) and reactive oxygen species (ROS; a free radical containing oxygen). Unused intermediates may react with other molecules, resulting in the generation of damaging by-products such as lactic acid, while ROS may react with various cellular molecules, causing oxidative stress and cell death.
Signs and symptoms of mitochondrial disease vary, depending on the organ or organ systems involved. Possible indications include developmental delay, reduced growth, fatigue, migraine, muscle weakness, muscle pain, cardiomyopathy, liver failure, blindness, optic atrophy (degeneration of the optic nerve), hearing loss, diabetes, and seizures. Clusters of signs and symptoms often emerge, indicating a discrete syndrome. For example, in individuals of age three months to two years, failure to thrive, progressive neurological degeneration (with decreased muscle tone, uncoordinated movement, and involuntary and repetitive muscle contraction), and visual, respiratory, and cardiac problems are characteristic of Leigh syndrome. Kearns-Sayre syndrome, on the other hand, is characterized primarily by progressive weakness or paralysis of the eye muscles and retinopathy (damage to the light-sensing retina of the eye), which can result in drooping eyelids and a loss of vision; onset typically is before age 20.
" height="20" alt="HEW Logo">
The diagnosis of mitochondrial disease is based on clinical features and, when possible, the results of genetic testing. Maternal family history of disease may provide important diagnostic insight, since inherited mitochondrial diseases are passed from the mother to her offspring and are transmitted strictly down maternal family lines. Persons affected by mitochondrial diseases may receive genetic counseling to assess the risk of passing on an inherited disorder.
Treatment for mitochondrial diseases is supportive. Optical aids, including lens replacement, and hearing aids, such as cochlear implants, may benefit individuals with visual or auditory deficits. Some patients may benefit from implanted cardiac pacemakers or defibrillators. Supportive therapies for deficiencies in specific ETC components may include oral administration of substances such as coenzyme Q10, l-creatine (creatine monohydrate), or riboflavin. Exercise may also help relieve symptoms in some individuals.